• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Restasis Contract Sales Force

Does anyone actually see the Green team lasting through Q2? Or will they cut Blue and keep Green to save money?

We certainly don't need three Vuity reps, two of whom have Restasis which is dying really quickly to generics.